Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07723703RecruitingPhase 1
Study of a new drug for acute myeloid leukemia and related blood cancer
This trial is testing a new medicine called AMX-883 for people with a type of blood cancer called acute myeloid leukemia (AML) or a high-risk blood disorder called myelodysplastic syndrome (MDS) that has come back or not responded to other treatments. The study hopes to see if the drug is safe and works, either alone or combined with another drug.
Fairfax, VirginiaAges 18 years+ - NCT07838285Recruiting
Why patients decline surgical research
This study looks at why some patients choose not to take part in surgical research. It aims to find ways to make it easier for patients to join future studies.
Al Mansurah, DakahliyaAges 18 years+ - NCT07820891RecruitingPhase 1
Healthy volunteer study for BGB-43395 drug interactions
This study tests whether a new medicine, BGB-43395, interacts with other drugs in healthy people. It helps doctors understand how the drug is processed, which is important for future patients.
Dallas, TexasAges 18–65 - NCT07815561RecruitingPhase 1
Testing a new drug for safety in healthy adults
This study tests a new medicine called SAB01 in healthy adults to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this is the first time the drug is given to people.
Cypress, CaliforniaAges 18–55 - NCT07801300RecruitingPhase 1
Study of a new drug for inflammation and healthy volunteers
This study tests a new drug called LY5625575 in healthy people and in people with inflammation (measured by a blood test called C-reactive protein). The goal is to see if the drug is safe and how the body processes it.
Miami, FloridaAges 18–65 - NCT07803835RecruitingPhase 1
Study of MWX401 for healthy adults and mild high blood pressure
This study tests a new medicine, MWX401, to see if it is safe and how it works in the body. It includes healthy adults and people with mild high blood pressure, with frequent check-ups to ensure safety.
Nanjing, JiangsuAges 18–60 - NCT07784699RecruitingPhase 1
Testing an experimental pill for weight loss in healthy or overweight adults
This study tests an experimental pill (GZC8072) for weight loss. It is a phase 1 trial, meaning it is one of the first times the drug is given to people, and the focus is on safety and how the body handles it. You would receive either a single dose (if you are healthy) or multiple doses (if you are overweight or obese) to see how the medication works.
BeijingAges 18–55 - NCT07787169RecruitingPhase 1
Study of amyloid-targeting therapies for Alzheimer's disease
This study tests several new experimental medications that target amyloid plaques, the protein clumps linked to Alzheimer's disease. It aims to find out if these treatments are safe and well-tolerated in people with early-stage Alzheimer's and in healthy volunteers.
Anaheim, CaliforniaAges 18–85 - NCT07780383RecruitingPhase 1
Single-dose study for healthy adults and early Alzheimer's participants
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
Anaheim, CaliforniaAges 18–80 - NCT07783503RecruitingPhase 1
Drug interaction study of pelabresib in healthy adults
This study tests how two other drugs affect the levels of the study drug pelabresib in healthy people. It aims to see if taking these drugs together changes how the body processes pelabresib.
NottinghamAges 18–55 - NCT07776418Recruiting
How different snacks affect appetite after eating
This study tests how different snack bars affect your hunger, fullness, and digestion in the hours after eating. You may be eligible if you eat snacks regularly and are interested in how your body responds to food.
LondonAges 35–65 - NCT07782593Recruiting
Snack bars for appetite and gut health in UK adults
This study is testing how certain snack bars affect appetite, fullness, and gut health in adults. Participants will eat the snack bars regularly for a period and have their responses measured. To join, you need to live in the UK, snack regularly, and have a low fiber diet.
LondonAges 35–65 - NCT07769489RecruitingPhase 1
Comfort study of larger under-the-skin injections
This study checks if giving larger volumes of liquid under the skin (subcutaneous injection) at different speeds is comfortable and acceptable to healthy people. It aims to see how the body reacts to help make future injections more comfortable for patients.
Gentofte MunicipalityAges 18–64 - NCT07775261RecruitingPhase 1
Testing a new drug in healthy volunteers
This study tests a new medicine called Lu AH69593 in healthy people to see how safe it is and how the body handles it. Participants will stay at the clinic for a short time. This is an early-stage trial, so it may not directly help you, but it helps develop future treatments.
Madison, WisconsinAges 18–55 - NCT07763418RecruitingPhase 1
Kidney function study of golcadomide
This study tests how a new drug, golcadomide, works in people with severe kidney problems compared to those with normal kidneys. It helps see if the drug needs different dosing for patients with kidney issues.
Chandler, ArizonaAges 18–84 - NCT07756996RecruitingPhase 1
How a new depression pill is absorbed in the body
This study tests whether a new version of an antidepressant pill is absorbed the same way as the existing one, and whether food changes how it is absorbed. Participants take the pill and have blood tests to measure drug levels.
Suzhou, JiangsuAges 18–65 - NCT07741461RecruitingPhase 1
Testing ACT201 for chronic hepatitis B
This trial tests a new medication called ACT201 in two parts: one for healthy volunteers and one for people with chronic hepatitis B. For participants with hepatitis B, the drug may help control the infection, and the study will check its safety and how well it works.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07744802RecruitingPhase 1
Drug interaction study of vimseltinib in healthy men
This study is for healthy men to see how a new drug called vimseltinib affects a protein in your body that helps remove other drugs. Participation will help your doctors understand how to use this drug safely in the future.
Overland Park, KansasAges 18–55 - NCT07723833RecruitingPhase 1
Study of different forms of elecoglipron in healthy volunteers
This trial tests how different versions of the drug elecoglipron are absorbed by the body and if they are safe. It is for healthy people to help find the best way to take the medicine.
Glendale, CaliforniaAges 18–55 - NCT07715149RecruitingPhase 1
D-2570 study for people with and without liver issues
This trial tests how a drug called D-2570 is processed in people with different levels of liver function. It compares people with liver impairment to those with healthy livers to see how the drug moves through the body.
Bengbu, AnhuiAges 18–70 - NCT07721597RecruitingEarly Phase 1
Testing ZP6590 in Men of Various Weights
This trial tests an experimental medication called ZP6590 given as injections. It's for men who are at a normal weight, overweight, or have obesity, and studies how safe and well-tolerated the drug is in different doses.
Neuss, North Rhine-WestphaliaAges 18–60 - NCT07712939RecruitingPhase 1
Study of CND319 for rheumatic diseases
This study tests a new drug called CND319 in healthy volunteers and people with rheumatoid arthritis or Sjögren's disease. The goal is to see if it is safe and how the body responds to it.
Melbourne, VictoriaAges 18–65 - NCT07713485RecruitingPhase 1
XmAb412 study in healthy adults
This is a first-in-human study testing a new drug called XmAb412 in healthy volunteers. It helps researchers understand how the drug works in the body and if it's safe.
Joondalup, Western AustraliaAges 18–55 - NCT07702890RecruitingPhase 1/Phase 2
Testing a new drug for obesity and type 2 diabetes
This trial tests an investigational drug called GUB-UCN2 in people who are healthy, overweight, or have type 2 diabetes. The goal is to see if the drug is safe and how the body processes it.
NeussAges 18–75
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.